Carcinoembryonic antigen expression in stages I and II breast cancer: its relationship with clinicopathologic factors

Human Pathology
A S SundbladL Ricci

Abstract

Carcinoembryonic antigen (CEA) has been detected by immunohistochemistry in breast carcinoma, but its relationship with prognosis is still unclear. This difficulty may be because of the great variety of antibodies used for its determination. In the present study, 271 stages I and II breast carcinomas are analyzed by immunohistochemistry, using T84.66 antibody, a well-known highly specific CEA antibody. The results show that CEA expression was not associated with any of the clinicopathologic factors analyzed. Factors associated with disease-free survival (DFS) after univariate logistic regression analyses were tumor size smaller than 2 cm (P = .01), lymph node free of metastases (P = .0000), low nuclear grade (P = .007), absence of c-erbB-2 overexpression (P = .02), and bcl-2 (P = .005) and CEA expression (P = .005), whereas those significantly associated with a better overall survival (OS) were tumor size small than 2 cm (P = .002), lymph node free of metastases (P = .0001), low nuclear grade (P = .01), low histological grade (P = .02), absence of c-erbB-2 overexpression (P = .002) and bcl-2 expression (P = .01). After multivariate stepwise regression analysis, lymph node free of metastases (P = .0000), CEA expression (P = .001...Continue Reading

References

Mar 24, 1979·British Medical Journal·S ShoushaP J Scheuer
Jun 25, 1992·The New England Journal of Medicine·W L McGuire, G M Clark
Feb 15, 1985·International Journal of Cancer. Journal International Du Cancer·R HartfielM M Brentani
Feb 1, 1984·Cancer·T P WaalkesD S Ettinger
Jul 1, 1994·Cancer·E G MansourL Dressler

❮ Previous
Next ❯

Citations

Apr 6, 2001·Hybridoma·F ZhangK L O'Neill
Nov 16, 2006·Cancer Biotherapy & Radiopharmaceuticals·Anna Maria BerghellaDomenico Adorno
Oct 9, 1998·Journal of Cutaneous Pathology·H InoueA Ishibashi
Nov 24, 2012·The British Journal of Surgery·S SaadatmandP J K Kuppen
Feb 6, 2004·Molecular & Cellular Proteomics : MCP·Jeffrey S RossGabriel N Hortobagyi
Jan 7, 2000·Journal of Cellular Physiology·S MénardS M Pupa
Apr 16, 2002·British Journal of Cancer·F G EbelingD Seidel
Nov 22, 2017·Journal for Immunotherapy of Cancer·Patrick M DillonCraig L Slingluff
May 2, 2009·Clinical and Experimental Medicine·David Siu
Aug 5, 2003·The Oncologist·Jeffrey S RossKenneth J Bloom
Aug 1, 1997·Cancer Biotherapy & Radiopharmaceuticals·P PellegriniC U Casciani
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Akira OhkiaMark E Stearns
Nov 17, 2020·Oncotarget·Marc B BechmannRené Villadsen
Dec 16, 2010·Analytical Chemistry·Rükan GençCiara K O'Sullivan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.